Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5598206 | Annals of Vascular Surgery | 2017 | 23 Pages |
Abstract
There are potential advantages to CG-EVAR with off-the-shelf availability, versatility, and low-profile devices. In this series, patients treated by CG-EVAR showed promising and durable midterm results compared with F-EVAR. CG-EVAR and F-EVAR should not be apprehended as opposed strategies but more as complementary ones, while the best indications for CG-EVAR are clarified.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Caroline Caradu, Julien Morin, Mathieu Poirier, Dominique Midy, Eric Ducasse,